Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những xu hướng nghiên cứu, những ảnh hưởng của COVID-19 đối với đời sống con người. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài. 

SCIENCEDIRECT

1. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?

Clinical Immunology Communications, 23 December 2021, Volume 2 (Cover date: December 2022), Pages 1-5

Zafran Khan, Ubaid Ahmad, Nasib Zaman
https://www.sciencedirect.com/science/article/pii/S2772613421000147/pdfft?md5=f005b5e6811cb9abe9678febb5aa3d6a&pid=1-s2.0-S2772613421000147-main.pdf

2. RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens
Structure, 4 November 2021, Volume 30, Issue 1 (Cover date: 6 January 2022), Pages 55-68.e2

David S. Goodsell, Stephen K. Burley

https://www.sciencedirect.com/science/article/pii/S0969212621003762/pdfft?md5=2362927393c4561d49ade893b3a363e1&pid=1-s2.0-S0969212621003762-main.pdf

3. Isothermal gene amplification coupled MALDI-TOF MS for SARS-CoV-2 detection

Talanta, 8 February 2022, Volume 242 (Cover date: 15 May 2022), Article 123297

Guobin Han, Qiuyuan Lin, Liang Qiao
https://www.sciencedirect.com/science/article/pii/S0039914022000935/pdfft?md5=8f165b28cdd4a99fcf9a164a921ae2e7&pid=1-s2.0-S0039914022000935-main.pdf

4. Immune responses to human respiratory coronaviruses infection in mouse models
Current Opinion in Virology, 11 December 2021, Volume 52 (Cover date: February 2022), Pages 102-111

Zhen Zhuang, Donglan Liu, Jincun Zhao
https://www.sciencedirect.com/science/article/pii/S1879625721001565/pdfft?md5=7c5a92231b080e575bbb3ea8bad21656&pid=1-s2.0-S1879625721001565-main.pdf

5. Clinical features and mechanistic insights into drug repurposing for combating COVID-19

The International Journal of Biochemistry & Cell Biology, 5 November 2021, Volume 142 (Cover date: January 2022), Article 106114

Purva Asrani, Keshav Tiwari, Sukhwinder Singh Sohal
https://www.sciencedirect.com/science/article/pii/S1357272521001953/pdfft?md5=76d0589ff5d346d116450b5eb9398db6&pid=1-s2.0-S1357272521001953-main.pdf

6. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals

Journal of Allergy and Clinical Immunology, Available online 21 January 2022, In press, corrected proof

Min Li, Jiaojiao Liu, Xia Jin
https://www.sciencedirect.com/science/article/pii/S0091674922000732/pdfft?md5=f754a0facc897afd8f93e06c1c620447&pid=1-s2.0-S0091674922000732-main.pdf

7. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status

Vaccine, 3 December 2021, Volume 40, Issue 3 (Cover date: 24 January 2022), Pages 531-535

François Helle, Julien Moyet, Etienne Brochot
https://www.sciencedirect.com/science/article/pii/S0264410X21015589/pdfft?md5=86908ab28df9794e218c8dcfc3979ebb&pid=1-s2.0-S0264410X21015589-main.pdf

8. Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
Biosafety and Health, Available online 3 January 2022, In press, corrected proof

Sheng Wang, Lizhen Liu, Hong Shao

https://www.sciencedirect.com/science/article/pii/S2590053621001269/pdfft?md5=a5a5258a5e01f2835032ece3498a7087&pid=1-s2.0-S2590053621001269-main.pdf

9. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
Human Immunology, 8 September 2021, Volume 83, Issue 1 (Cover date: January 2022), Pages 86-98

Mehran Ghasemzadeh, Alireza Ghasemzadeh, Ehteramolsadat Hosseini

https://www.sciencedirect.com/science/article/pii/S0198885921002305/pdfft?md5=158972f8afc98ec907424a6c4bf599f4&pid=1-s2.0-S0198885921002305-main.pdf

10. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Virus Research, 14 November 2021, Volume 308 (Cover date: 15 January 2022), Article 198631

Sujay Paul, Luis Alberto Bravo Vázquez, Aashish Srivastava
https://www.sciencedirect.com/science/article/pii/S0168170221003385/pdfft?md5=f57b4fa55d64cb501aa7ee9ca1f32c4e&pid=1-s2.0-S0168170221003385-main.pdf

11. Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2
Computational and Structural Biotechnology Journal, 11 January 2022, Volume 20 (Cover date: 2022), Pages 573-582

Yipeng Cao, Rui Yang, Zhiyong Yuan
https://www.sciencedirect.com/science/article/pii/S2001037022000149/pdfft?md5=01f3be50d0558f8fd6173cc2c9d34e89&pid=1-s2.0-S2001037022000149-main.pdf

12. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review

Annals of Oncology, 28 October 2021, Volume 33, Issue 2 (Cover date: February 2022), Pages 158-168

C. Corti, G. Antonarelli, G. Curigliano

https://www.sciencedirect.com/science/article/pii/S0923753421045506/pdfft?md5=1ebb3081fc3dadd6084d475de21ca114&pid=1-s2.0-S0923753421045506-main.pdf

13. Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: Genetic relations and vaccine strain match

Virus Research, 21 January 2022, Volume 311 (Cover date: 2 April 2022), Article 198688

Paula Perbolianachis, Diego Ferla, Juan Cristina

https://www.sciencedirect.com/science/article/pii/S0168170222000168/pdfft?md5=0c32e50788d6879f6827298509e09054&pid=1-s2.0-S0168170222000168-main.pdf

14. A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines

New Microbes and New Infections, 7 January 2022, Volume 45 (Cover date: January 2022), Article 100949

R. Joshi, R. Singla, B. Medhi

https://www.sciencedirect.com/science/article/pii/S2052297522000014/pdfft?md5=3151bad827fccbd0c19019393042b507&pid=1-s2.0-S2052297522000014-main.pdf

15. Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics

Gene Reports, 2 February 2022, Volume 26 (Cover date: March 2022), Article 101537

Abozar Ghorbani, Samira Samarfard, Keramatollah Izadpanah

https://www.sciencedirect.com/science/article/pii/S2452014422000450/pdfft?md5=cd986d0e656c53398819813379b175de&pid=1-s2.0-S2452014422000450-main.pdf

16. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients

Human Immunology, 4 November 2021, Volume 83, Issue 2 (Cover date: February 2022), Pages 119-129

Haitao Xiang, Yingze Zhao, Penghui Yang

https://www.sciencedirect.com/science/article/pii/S0198885921002524/pdfft?md5=6369706a9b5696c17ea06d5c11592ab5&pid=1-s2.0-S0198885921002524-main.pdf

17. Therapeutics for COVID-19 and post COVID-19 complications: An update

Current Research in Pharmacology and Drug Discovery, Available online 4 February 2022 In press, journal pre-proof, Article 100086

Debdoot Basu, Vivek P. Chavda, Anita A. Mehta

https://www.sciencedirect.com/science/article/pii/S2590257122000062/pdfft?md5=b5f3cbf17e00ca66fa356c7044406ca3&pid=1-s2.0-S2590257122000062-main.pdf

18. Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review

Journal of Virological Methods, 24 November 2021, Volume 300 (Cover date: February 2022), Article 114375

Fatima Akram, Ikram ul Haq, Rukhma Sattar

https://www.sciencedirect.com/science/article/pii/S0166093421003141/pdfft?md5=74bb68ab9f0bd081451e01ac648b30ad&pid=1-s2.0-S0166093421003141-main.pdf

19. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

American Journal of Kidney Diseases, 8 September 2021, Volume 79, Issue 2 (Cover date: February 2022), Pages 185-192.e1

Ilias Bensouna, Valérie Caudwell, Pierre Housset

https://www.sciencedirect.com/science/article/abs/pii/S0272638621008337

20. Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab

Multiple Sclerosis and Related Disorders, 9 November 2021, Volume 57 (Cover date: January 2022), Article 103382

J. D. Katz, A. J. Bouley, E. S. Lathi

https://www.sciencedirect.com/science/article/pii/S2211034821006490/pdfft?md5=fb2e1a05a1e62ad68f5eab6e2b27c1ba&pid=1-s2.0-S2211034821006490-main.pdf

21. Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia

Infection, Genetics and Evolution, 18 December 2021, Volume 97 (Cover date: January 2022), Article 105192

Jubby Marcela Gálvez, Henry Mauricio Chaparro-Solano, Ángela María Ruiz-Sternberg

https://www.sciencedirect.com/science/article/pii/S1567134821004925/pdfft?md5=163307288831f4d73a4fe911eeed05d6&pid=1-s2.0-S1567134821004925-main.pdf

WILEY

1. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis

Adithan Ganesh, Michael D. Randall

First published: 04 February 2022

https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.15258

2. Clinical impact and benefits of a simultaneous cardio-pulmonary rehabilitation in a COVID-19-infected patient following cardiac arrest: A case report

Mirim Lee, Jeong Jae Lee, Jun young Ko, Yong Kyun Kim, Seungbok Lee

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.5345

3. Comparing humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and healthy controls: an Austrian prospective multi-center cohort study

Gabriel Bsteh, Harald Hegen, Gerhard Traxler, Nik Krajnc, Fritz Leutmezer, Franziska Di Pauli, Barbara Kornek, Paulus Rommer, Gudrun Zulehner, Sophie Dürauer, Angelika Bauer …

First published: 01 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.15265

4. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant

Dandan Tian, Yanhong Sun, Huihong Xu, Qing Ye

First published: 03 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27643

5. Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients – A Czech Multicenter Experience

Barbora Weinbergerová, Ivo Demel, Benjamin Víšek, Jan Válka, Martin Čerňan, Pavel Jindra, Jan Novák, Lukáš Stejskal, Flóra Kovácsová, Tomáš Kabut, Tomáš Szotkowski, Roman Hájek…

First published: 04 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2974

6. Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes

Sandra Gray-Rodriguez, Melanie P. Jensen, Maria Otero-Jimenez, Brian Hanley, Olivia C. Swann, Patrick A. Ward, Francisco J. Salguero, Nadira Querido, Ildiko Farkas, Elisavet Velentza-Almpani…

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/path.5878

7. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2

Ismail Celik, Trina E. Tallei

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcb.30226

8. Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies

Adam J. Kanack PhD, Bandana Singh PhD, Gemlyn George MBBS, Krishna Gundabolu MBBS MS, Scott A. Koepsell MD PhD, Mouhamed Yazan Abou-Ismail MD, Karen A. Moser MD

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.26488

9. SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion

Federica Quaglia, Edoardo Salladini, Marco Carraro, Giovanni Minervini, Silvio C.E. Tosatto, Philippe Le Mercier

First published: 02 February 2022

https://febs.onlinelibrary.wiley.com/doi/epdf/10.1111/febs.16379

10. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation

Liang-Chang Hu, Chuan-Hua Ding, Hong-Ying Li, Zhen-Zhen Li, Ying Chen, Li-Peng Li, Wan-Zhong Li, Wen-Shan Liu

First published: 06 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jfbc.14085

11. Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach

Dr. Milan Sencanski, Dr. Vladimir Perovic, Dr. Jelena Milicevic, Dr. Tamara Todorovic, Dr. Radivoje Prodanovic, Dr. Veljko Veljkovic, Dr. Slobodan Paessler, Dr. Sanja Glisic

First published: 01 February 2022

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/open.202100248

12. Modeling the factors that influence exposure to SARS-CoV-2 on a subway train carriage

Daniel Miller, Marco-Felipe King, James Nally, Joseph R. Drodge, Gary I. Reeves, Andrew M. Bate, Henry Cooper, Ursula Dalrymple, Ian Hall, Martín López-García, Simon T. Parker, Catherine J. Noakes

First published: 08 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ina.12976

13. Direct inactivation of SARS-CoV-2 by low level Blue Photobiomodulation LED at 470, 454 and 450 nm

Luisa Zupin, Rossella Gratton, Margherita Milani, Libera Clemente, Francesco Fontana, Maurizio Ruscio, Sergio Crovella

First published: 06 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbio.202100375

SPRINGER NATURE

1. Pre-COVID-19 Social Determinants of Health Among Mexican Migrants in Los Angeles and New York City and Their Increased Vulnerability to Unfavorable Health Outcomes During the COVID-19 Pandemic

Mireya Vilar-Compte, Pablo Gaitán-Rossi… in Journal of Immigrant and Minority Health (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10903-021-01283-8.pdf

2. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months

Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş in Clinical Rheumatology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10067-021-05942-x.pdf

3. Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

Daniela Poli, Emilia Antonucci, Walter Ageno… in Internal and Emergency Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11739-021-02891-w.pdf

4. Applications of nanomaterials in COVID-19 pandemic

Mei-Fang Xiao, Chang Zeng, Shao-Hui Li, Fu-Lai Yuan in Rare Metals (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12598-021-01789-y.pdf

5. Increased psychological distress after the lifting of COVID-19 lockdown in the Saudi population: a cross-sectional study

Hatim Yousef Alharbi, Sami S. Alharthi… in Middle East Current Psychiatry (2022)

https://link.springer.com/content/pdf/10.1186%2Fs43045-021-00167-9.pdf

6. The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database

Norihiko Ikeda, Hiroyuki Yamamoto, Akinobu Taketomi, Taizo Hibi… in Surgery Today (2022)

https://link.springer.com/content/pdf/10.1007%2Fs00595-021-02406-2.pdf

7. The moderating effect of solar radiation on the association between human mobility and COVID-19 infection in Europe

Wenyu Zhao, Yongjian Zhu, Jingui Xie… in Environmental Science and Pollution Resear… (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11356-021-15738-w.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html

Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html

Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 18/2/2022